Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial

Daniel Rea; Louise Hiller; HM Earl; JA Dunn; Sarah Bathers; David Spooner; Robert Grieve; RK Agrawal; Christopher Poole; NEAT Investigators

Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial

Daniel Rea
, Louise Hiller
, HM Earl
, JA Dunn
, Sarah Bathers
, David Spooner
, Robert Grieve
, RK Agrawal
, Christopher Poole
, NEAT Investigators

Research output: Contribution to journal › Article

Original language	English
Article number	suppl 595
Number of pages	1
Journal	Proceedings of the American Society of Clinical Oncology
Volume	23
Publication status	Published - 1 Jan 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Rea, D., Hiller, L., Earl, HM., Dunn, JA., Bathers, S., Spooner, D., Grieve, R., Agrawal, RK., Poole, C., & NEAT Investigators (2004). Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial. Proceedings of the American Society of Clinical Oncology, 23, Article suppl 595.

@article{9136559006354ef090ef57d059a25e91,

title = "Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial",

author = "Daniel Rea and Louise Hiller and HM Earl and JA Dunn and Sarah Bathers and David Spooner and Robert Grieve and RK Agrawal and Christopher Poole and \{NEAT Investigators\}",

year = "2004",

month = jan,

day = "1",

language = "English",

volume = "23",

journal = "Proceedings of the American Society of Clinical Oncology",

}

Rea, D, Hiller, L, Earl, HM, Dunn, JA, Bathers, S, Spooner, D, Grieve, R, Agrawal, RK, Poole, C & NEAT Investigators 2004, 'Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial', Proceedings of the American Society of Clinical Oncology, vol. 23, suppl 595.

Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial. / Rea, Daniel; Hiller, Louise; Earl, HM et al.
In: Proceedings of the American Society of Clinical Oncology, Vol. 23, suppl 595, 01.01.2004.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer

T2 - a non-radnomised comparison of patients treated in the NEAT trial

AU - Rea, Daniel

AU - Hiller, Louise

AU - Earl, HM

AU - Dunn, JA

AU - Bathers, Sarah

AU - Spooner, David

AU - Grieve, Robert

AU - Agrawal, RK

AU - Poole, Christopher

AU - NEAT Investigators

PY - 2004/1/1

Y1 - 2004/1/1

M3 - Article

VL - 23

JO - Proceedings of the American Society of Clinical Oncology

JF - Proceedings of the American Society of Clinical Oncology

M1 - suppl 595

ER -